Oliver Lagore Vanvalin Investment Group Neogenomics Inc Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Neogenomics Inc stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 400 shares of NEO stock, worth $5,396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$5,396
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NEO
# of Institutions
296Shares Held
125MCall Options Held
698KPut Options Held
116K-
Black Rock Inc. New York, NY19.7MShares$265 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$189 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$92.9 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$89.1 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$88.2 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.7B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...